Effect of Medication Reconciliation at Hospital Admission on 30-Day Returns to Hospital: A Randomized Clinical Trial.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 09 2021
Historique:
entrez: 16 9 2021
pubmed: 17 9 2021
medline: 13 1 2022
Statut: epublish

Résumé

According to international recommendations, hospitals should use medication reconciliation to prevent medication errors and improve patient safety. To assess the impact of medication reconciliation at hospital admission on patient-centered health care outcomes. This parallel group, open-label randomized controlled trial used centralized randomization to the intervention group (ie, individuals with medication reconciliation) or control group (ie, individuals with only standard, physician-acquired medication history). Outcome assessors and data analysts were blinded to group allocation. Participants included 1702 patients aged 85 years or older, with more than 10 medications at hospital admission, or meeting both conditions at 2 regional secondary teaching hospitals in southern Switzerland. Study duration was 14.5 months, from November 1, 2018, to January 15, 2020. Data were analyzed from December 2018 through March 2020. Medication reconciliation was performed at hospital admission in 3 steps: (1) the pharmacy assistant obtained the list of the patient's current medications (ie, the best possible medication history [BPMH]); (2) the clinical pharmacist led reconciliation of the BPMH with the list of home medications recorded at hospital admission by the attending physician (according to the hospital standard procedure); and (3) medication discrepancies were communicated to the attending physician, and, when necessary, medications prescribed at admission were adapted. The primary outcome was a composite postdischarge health care use variable quantified as the proportion of patients with unplanned all-cause hospital visits (including visits to the emergency department and hospital readmissions) within 30 days after discharge from the hospital when medication reconciliation took place. A time-to-event analysis was performed. Among 1702 patients (median [interquartile range] age, 86.0 [79.0-89.0] years; 720 [42.3%] men), 866 patients (50.9%) were allocated to the intervention group and 836 patients (49.1%) to the control group. The primary outcome occurred among 340 participants (39.3%) in the intervention group and 330 participants (39.5%) in the control group (P = .93). In time-to-event analyses at study closeout, unplanned all-cause hospital visits to the emergency department (log-rank P = .08) and unplanned all-cause hospital readmissions (log-rank P = .10) occurred similarly in the intervention and control groups. These findings suggest that medication reconciliation at hospital admission has no impact on postdischarge health care outcomes among patients aged 85 years or older, with more than 10 medications at hospital admission, or meeting both conditions. ClinicalTrials.gov Identifier: NCT03654963.

Identifiants

pubmed: 34529065
pii: 2784184
doi: 10.1001/jamanetworkopen.2021.24672
pmc: PMC8446815
doi:

Banques de données

ClinicalTrials.gov
['NCT03654963']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2124672

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Références

BMJ. 2017 Jan 13;356:i5336
pubmed: 28087590
BMC Health Serv Res. 2014 Mar 13;14:125
pubmed: 24620750
BMC Health Serv Res. 2016 May 10;16:173
pubmed: 27160080
Arch Intern Med. 2005 Feb 28;165(4):424-9
pubmed: 15738372
Am J Med. 2011 Feb;124(2):136-43
pubmed: 21295193
BMJ Open. 2019 May 27;9(5):e026259
pubmed: 31133583
Drugs Aging. 2004;21(12):793-811
pubmed: 15382959
Cochrane Database Syst Rev. 2018 Aug 23;8:CD010791
pubmed: 30136718
BMC Geriatr. 2017 Oct 10;17(1):230
pubmed: 29017448
N Engl J Med. 1979 May 31;300(22):1242-5
pubmed: 431682
JAMA Intern Med. 2018 Mar 1;178(3):375-382
pubmed: 29379953
Br J Clin Pharmacol. 2015 Oct;80(4):796-807
pubmed: 25619317
Am J Health Syst Pharm. 2019 Dec 2;76(24):2028-2040
pubmed: 31789354
BMJ Qual Saf. 2018 Dec;27(12):947-949
pubmed: 30355674
PLoS One. 2018 Mar 28;13(3):e0193510
pubmed: 29590146
Res Social Adm Pharm. 2021 Jul;17(7):1306-1312
pubmed: 33023830
Arch Intern Med. 2012 Jul 23;172(14):1057-69
pubmed: 22733210
BMJ Open. 2017 Mar 16;7(3):e013647
pubmed: 28302636
JAMA. 2003 Mar 5;289(9):1107-16
pubmed: 12622580
Br J Clin Pharmacol. 2004 Jan;57(1):6-14
pubmed: 14678335
Am J Health Syst Pharm. 2019 Dec 2;76(24):1996-1997
pubmed: 31789356
Res Social Adm Pharm. 2020 Aug;16(8):995-1002
pubmed: 31883776

Auteurs

Alessandro Ceschi (A)

Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Clinical Trial Unit, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.
Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Zurich, Switzerland.

Roberta Noseda (R)

Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.

Michela Pironi (M)

Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Hospital Pharmacy Service, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.

Nicole Lazzeri (N)

Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Hospital Pharmacy Service, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.

Ottavia Eberhardt-Gianella (O)

Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Hospital Pharmacy Service, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.

Saida Imelli (S)

Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Hospital Pharmacy Service, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.

Sara Ghidossi (S)

Division of Clinical Pharmacology and Toxicology, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Hospital Pharmacy Service, Institute of Pharmacological Sciences of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland.

Stefano Bruni (S)

Department of Information and Communications Technology, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.

Alberto Pagnamenta (A)

Clinical Trial Unit, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Department of Intensive Care, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Division of Pneumology, University of Geneva, Geneva, Switzerland.

Paolo Ferrari (P)

Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland.
Department of Nephrology, Ente Ospedaliero Cantonale, Lugano, Switzerland.
Prince of Wales Hospital Clinical School, University of New South Wales, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH